{"id":"https://openalex.org/W2137334382","doi":"https://doi.org/10.2337/dc09-0533","title":"Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes","display_name":"Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes","alternate_titles":[],"publication_year":2009,"publication_date":"2009-06-19","ids":{"openalex":"https://openalex.org/W2137334382","doi":"https://doi.org/10.2337/dc09-0533","mag":"2137334382","pmid":"https://pubmed.ncbi.nlm.nih.gov/19542207","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2732140"},"language":"en","primary_location":{"id":"doi:10.2337/dc09-0533","doi":"https://doi.org/10.2337/dc09-0533","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc09-0533","pdf_url":"https://diabetesjournals.org/care/article-pdf/32/9/1663/665678/zdc00909001663.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2137334382"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://diabetesjournals.org/care/article-pdf/32/9/1663/665678/zdc00909001663.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023778123","display_name":"Claus Morten Larsen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claus M. Larsen","raw_affiliation_strings":["Hagedorn Research Institute and Steno Diabetes Center, Gentofte, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hagedorn Research Institute and Steno Diabetes Center, Gentofte, Denmark;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084531350","display_name":"Mirjam V. Faulenbach","orcid":"https://orcid.org/0009-0006-5255-869X","observed_orcids":["https://orcid.org/0009-0006-5255-869X"]},"institutions":[{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Mirjam Faulenbach","raw_affiliation_strings":["Clinic for Endocrinology and Diabetes, University Hospital Zurich, Zurich, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic for Endocrinology and Diabetes, University Hospital Zurich, Zurich, Switzerland;","institution_ids":["https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069291545","display_name":"Allan Arthur Vaag","orcid":"https://orcid.org/0000-0002-3690-2191","observed_orcids":["https://orcid.org/0000-0002-3690-2191"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Allan Vaag","raw_affiliation_strings":["Hagedorn Research Institute and Steno Diabetes Center, Gentofte, Denmark;","University of Lund, Lund, Sweden;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hagedorn Research Institute and Steno Diabetes Center, Gentofte, Denmark;","institution_ids":[]},{"raw_affiliation_string":"University of Lund, Lund, Sweden;","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013450317","display_name":"Jan A. Ehses","orcid":"https://orcid.org/0000-0001-9066-7607","observed_orcids":["https://orcid.org/0000-0001-9066-7607"]},"institutions":[{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Jan A. Ehses","raw_affiliation_strings":["Clinic for Endocrinology and Diabetes, University Hospital Zurich, Zurich, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic for Endocrinology and Diabetes, University Hospital Zurich, Zurich, Switzerland;","institution_ids":["https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017674179","display_name":"Marc Yves Donath","orcid":"https://orcid.org/0000-0002-3143-5045","observed_orcids":["https://orcid.org/0000-0002-3143-5045"]},"institutions":[{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Marc Y. Donath","raw_affiliation_strings":["Clinic for Endocrinology and Diabetes, University Hospital Zurich, Zurich, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic for Endocrinology and Diabetes, University Hospital Zurich, Zurich, Switzerland;","institution_ids":["https://openalex.org/I4210100468"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010404114","display_name":"Thomas R Mandrup-Poulsen","orcid":"https://orcid.org/0000-0002-3215-9273","observed_orcids":["https://orcid.org/0000-0002-3215-9273"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["DK","SE"],"is_corresponding":true,"raw_author_name":"Thomas Mandrup-Poulsen","raw_affiliation_strings":["Core Unit for Medical Research Methodology, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark;","Hagedorn Research Institute and Steno Diabetes Center, Gentofte, Denmark;","Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Core Unit for Medical Research Methodology, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark;","institution_ids":["https://openalex.org/I124055696"]},{"raw_affiliation_string":"Hagedorn Research Institute and Steno Diabetes Center, Gentofte, Denmark;","institution_ids":[]},{"raw_affiliation_string":"Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5010404114"],"corresponding_institution_ids":["https://openalex.org/I124055696","https://openalex.org/I28166907"],"apc_list":null,"apc_paid":null,"fwci":20.9588,"has_fulltext":true,"cited_by_count":442,"citation_normalized_percentile":{"value":0.9968803,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"32","issue":"9","first_page":"1663","last_page":"1668"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.8403000235557556,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.8403000235557556,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.1306000053882599,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.00800000037997961,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-1-receptor-antagonist","display_name":"interleukin-1 receptor antagonist","score":0.9750000238418579},{"id":"https://openalex.org/keywords/anakinra","display_name":"anakinra","score":0.9919999837875366},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9919999837875366},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.953000009059906},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.7379999756813049},{"id":"https://openalex.org/keywords/beta-cell-apoptosis","display_name":"beta-cell apoptosis","score":0.7139999866485596},{"id":"https://openalex.org/keywords/il-1-blockade","display_name":"IL-1 blockade","score":0.6679999828338623},{"id":"https://openalex.org/keywords/c-peptide","display_name":"C-peptide","score":0.6759999990463257},{"id":"https://openalex.org/keywords/proinsulin-insulin-ratio","display_name":"proinsulin/insulin ratio","score":0.9240000247955322},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.9079999923706055},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9869999885559082},{"id":"https://openalex.org/keywords/systemic-inflammation","display_name":"systemic inflammation","score":0.8240000009536743},{"id":"https://openalex.org/keywords/treatment-withdrawal","display_name":"treatment withdrawal","score":0.4650000035762787},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.6600000262260437}],"concepts":[{"id":"https://openalex.org/C2781228260","wikidata":"https://www.wikidata.org/wiki/Q415411","display_name":"Anakinra","level":3,"score":0.923622190952301},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8732964992523193},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6820008754730225},{"id":"https://openalex.org/C149892131","wikidata":"https://www.wikidata.org/wiki/Q14914156","display_name":"Interleukin 1 receptor antagonist","level":5,"score":0.6414861679077148},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5894424319267273},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5852354168891907},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5124619603157043},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.48505324125289917},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4826265275478363},{"id":"https://openalex.org/C2776828364","wikidata":"https://www.wikidata.org/wiki/Q1767180","display_name":"Beta cell","level":4,"score":0.4805367588996887},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.44536274671554565},{"id":"https://openalex.org/C2781195455","wikidata":"https://www.wikidata.org/wiki/Q422766","display_name":"C-reactive protein","level":3,"score":0.4371377229690552},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.428308367729187},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.4062159061431885},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.3429378271102905},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2882874608039856},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.26160603761672974},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0627693235874176},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C165220095","wikidata":"https://www.wikidata.org/wiki/Q207524","display_name":"Islet","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D050417","descriptor_name":"Insulin-Secreting Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D050417","descriptor_name":"Insulin-Secreting Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053590","descriptor_name":"Interleukin 1 Receptor Antagonist Protein","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D053590","descriptor_name":"Interleukin 1 Receptor Antagonist Protein","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D053590","descriptor_name":"Interleukin 1 Receptor Antagonist Protein","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":9,"locations":[{"id":"doi:10.2337/dc09-0533","doi":"https://doi.org/10.2337/dc09-0533","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc09-0533","pdf_url":"https://diabetesjournals.org/care/article-pdf/32/9/1663/665678/zdc00909001663.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmid:19542207","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19542207","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2732140","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2732140/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"Text"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/a0555d40-35a1-11df-8ed1-000ea68e967b","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/a0555d40-35a1-11df-8ed1-000ea68e967b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Larsen, C M, Faulenbach, M, Vaag, A, Ehses, J A, Donath, M Y & Mandrup-Poulsen, T 2009, 'Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes', Diabetes Care, vol. 32, no. 9, pp. 1663-8. https://doi.org/10.2337/dc09-0533","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:lup.lub.lu.se:b214e85e-56b3-41d4-ba9f-1b3eb362c2ee","doi":null,"is_oa":false,"landing_page_url":"https://lup.lub.lu.se/record/1492395","pdf_url":null,"source":{"id":"https://openalex.org/S4306400536","display_name":"Lund University Publications (Lund University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I187531555","host_organization_name":"Lund University","host_organization_lineage":["https://openalex.org/I187531555"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ISSN: 1935-5548","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:www.zora.uzh.ch:20.500.14742/42797","doi":null,"is_oa":true,"landing_page_url":"https://www.zora.uzh.ch/handle/20.500.14742/42797","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Larsen, C. M., Faulenbach, M., Vaag, A., Ehses, J. A., Donath, M. Y., & Mandrup-Poulsen, T. (2009). Sustained Effects of Interleukin-1-Receptor Antagonist Treatment in Type 2 Diabetes Mellitus. Diabetes Care, 32, 1663\u20131668. https://doi.org/10.2337/dc09-0533","raw_type":"Journal Article"},{"id":"doi:10.5167/uzh-19583","doi":"https://doi.org/10.5167/uzh-19583","is_oa":true,"landing_page_url":"https://doi.org/10.5167/uzh-19583","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.599.2500","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.599.2500","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://care.diabetesjournals.org/content/32/9/1663.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.664.7189","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.664.7189","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732140/pdf/zdc1663.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.2337/dc09-0533","doi":"https://doi.org/10.2337/dc09-0533","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc09-0533","pdf_url":"https://diabetesjournals.org/care/article-pdf/32/9/1663/665678/zdc00909001663.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2137334382.pdf","grobid_xml":"https://content.openalex.org/works/W2137334382.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1966977991","https://openalex.org/W1978062520","https://openalex.org/W2006313514","https://openalex.org/W2024337179","https://openalex.org/W2024378513","https://openalex.org/W2025908481","https://openalex.org/W2026094781","https://openalex.org/W2031475525","https://openalex.org/W2048211245","https://openalex.org/W2058455617","https://openalex.org/W2070914392","https://openalex.org/W2074685860","https://openalex.org/W2078830150","https://openalex.org/W2081276121","https://openalex.org/W2102076191","https://openalex.org/W2107158321","https://openalex.org/W2113145530","https://openalex.org/W2113544353","https://openalex.org/W2124620553","https://openalex.org/W2140432059","https://openalex.org/W2157982405","https://openalex.org/W2162746709","https://openalex.org/W2166089858","https://openalex.org/W2752336761","https://openalex.org/W4205321574","https://openalex.org/W4235025907","https://openalex.org/W4240175730","https://openalex.org/W6979199192"],"related_works":["https://openalex.org/W2024378513","https://openalex.org/W1997970555","https://openalex.org/W2333605563","https://openalex.org/W2000770852","https://openalex.org/W1979302001","https://openalex.org/W2314133680","https://openalex.org/W2155591528","https://openalex.org/W2117116174","https://openalex.org/W2171428576","https://openalex.org/W2062933233"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Interleukin":[1],"(IL)-1":[2],"impairs":[3],"insulin":[4],"secretion":[5],"and":[6,16,35,38,71,75,94,188,217],"induces":[7,211],"beta-cell":[8,11,36,108],"apoptosis.":[9],"Pancreatic":[10],"IL-1":[12,207],"expression":[13,21],"is":[14],"increased":[15],"interleukin-1":[17],"receptor":[18],"antagonist":[19],"(IL-1Ra)":[20],"reduced":[22],"in":[23,42,97,107,149,177,189],"patients":[24,43,63],"with":[25,30,44,147,209],"type":[26,45,66],"2":[27,46,67],"diabetes.":[28,47],"Treatment":[29],"recombinant":[31,86],"IL-1Ra":[32,161,174],"improves":[33],"glycemia":[34],"function":[37,109],"reduces":[39],"inflammatory":[40],"markers":[41,218],"Here":[48],"we":[49],"investigated":[50],"the":[51,126,165,202,214],"durability":[52],"of":[53,83,173,204,213,219],"these":[54],"responses.":[55],"RESEARCH":[56],"DESIGN":[57],"AND":[58],"METHODS:":[59],"Among":[60],"70":[61],"ambulatory":[62],"who":[64],"had":[65],"diabetes,":[68],"A1C":[69],">7.5%,":[70],"BMI":[72],">27":[73],"kg/m(2)":[74],"were":[76,95,199],"randomly":[77],"assigned":[78],"to":[79,118,141,183,194],"receive":[80],"13":[81,171],"weeks":[82,122,172,224],"anakinra,":[84],"a":[85,153],"human":[87],"IL-1Ra,":[88],"or":[89],"placebo,":[90],"67":[91],"completed":[92],"treatment":[93,226],"included":[96],"this":[98],"double-blind":[99],"39-week":[100],"follow-up":[101],"study.":[102,205],"Primary":[103],"outcome":[104],"was":[105,114],"change":[106],"after":[110,123,225],"anakinra":[111,124,210],"withdrawal.":[112,227],"Analysis":[113],"done":[115],"by":[116,156,170],"intention":[117],"treat.":[119],"RESULTS:":[120],"Thirty-nine":[121],"withdrawal,":[125],"proinsulin-to-insulin":[127],"(PI/I)":[128],"ratio":[129,216],"but":[130],"not":[131],"stimulated":[132,167],"C-peptide":[133,168],"remained":[134],"improved":[135,166],"(by":[136],"-0.07":[137],"[95%":[138],"CI":[139],"-0.14":[140],"-0.02],":[142],"P":[143,185,196],"=":[144,186,197],"0.011)":[145],"compared":[146],"values":[148],"placebo-treated":[150],"patients.":[151],"Interestingly,":[152],"subgroup":[154],"characterized":[155],"genetically":[157],"determined":[158],"low":[159],"baseline":[160],"serum":[162],"levels":[163],"maintained":[164,200],"obtained":[169],"treatment.":[175],"Reductions":[176],"C-reactive":[178],"protein":[179],"(-3.2":[180],"mg/l":[181],"[-6.2":[182],"-1.1],":[184],"0.014)":[187],"IL-6":[190],"(-1.4":[191],"ng/l":[192],"[-2.6":[193],"-0.3],":[195],"0.036)":[198],"until":[201],"end":[203],"CONCLUSIONS:":[206],"blockade":[208],"improvement":[212],"PI/I":[215],"systemic":[220],"inflammation":[221],"lasting":[222],"39":[223]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2137334382","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":30},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":31},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":23},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":25},{"year":2016,"cited_by_count":28},{"year":2015,"cited_by_count":31},{"year":2014,"cited_by_count":39},{"year":2013,"cited_by_count":44},{"year":2012,"cited_by_count":34}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
